Regeneron beats quarterly estimates on eczema drug demand; launches dividend program
Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema ...
Bellevue startup, armed with $320 million, undertakes ambitious project to aid medical research
Regeneron, San Diego-based biotech company Illumina and 17 health systems invested in the $320 million round. Regeneron ...
Yahoo Finance9d
Why Are Analysts Bullish on Regeneron Pharmaceuticals, Inc. (REGN) Now?
In this article, we are going to take a look at where Regeneron Pharmaceuticals ... which posted a gain of 23.31%, building on the 24.2% return in 2023. The two-year surge of over 53% is the ...
U.S. News & World Report8d
Regeneron Beats Quarterly Estimates on Eczema Drug Demand; Launches Dividend Program
(Reuters) - Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback ...